Therapeutic compounds containing xanthinyl
    3.
    发明授权
    Therapeutic compounds containing xanthinyl 失效
    含有黄原素的治疗化合物

    公开(公告)号:US6100271A

    公开(公告)日:2000-08-08

    申请号:US483871

    申请日:1995-06-07

    Abstract: Therapeutic compounds with at least one carboxylic acid, ester or amide-substituted side chain have the formula:CORE MOIETY --(R).sub.jwherein j is an integer from one to three. The core moiety is non-cyclic or cyclic (carbocyclic or heterocyclic). R may be selected from among hydrogen, halogen, hydroxyl, amino, substituted or unsubstituted C.sub.(1-10) alkyl, C.sub.(2-10) alkenyl, carbocyclic or heterocyclic groups and at least one R has the formula I: ##STR1## wherein: one or two p are the integer one, otherwise p is two; and n is an integer from three to twenty; R.sub.1 is selected from the group consisting of substituted and unsubstituted CH.sub.2 ; NR.sub.3, R.sub.3 being hydrogen, substituted or unsubstituted C.sub.(1-20) alkyl, C.sub.(1-20) alkoxyl, C.sub.(2-20) alkenyl or C.sub.(1-20) hydroxyalkyl, or carbocyclic or heterocyclic group; O; --CHR.sub.4 O--, R.sub.4 being substituted or unsubstituted C.sub.(1-20) alkyl, C.sub.(1-20) alkoxyl, C.sub.(2-20) alkenyl, C.sub.(1-20) hydroxyalkyl, or R.sub.2 and R.sub.4 join to form a substituted or unsubstituted heterocycle having four to seven ring atoms, the ether group --O-- of --CHR.sub.4 O-- being a member of the heterocycle. R.sub.2 is selected from the group consisting of hydrogen; halogen; substituted or unsubstituted C.sub.(1-10) alkyl; C.sub.(1-10) alkoxyl; C.sub.(2-10) alkenyl; C.sub.(1-10) hydroxyallyl; --A(R.sub.5).sub.m, A being N or O, m being one or two and R.sub.5 being hydrogen, a substituted or unsubstituted C.sub.(1-10) alkyl, C.sub.(1-10) alkoxyl, C.sub.(2-10) alkenyl or C.sub.(1-10) hydroxyalkyl), or carbocyclic or heterocyclic group. At least one of R.sub.1 is NR.sub.3, O or --CHR.sub.4 O--, or R.sub.2 is --A(R.sub.5).sub.m. The compounds and pharmaceutical compositions thereof are useful as therapies for diseases advanced via intracellular signaling through specific intracellular signaling pathways by mediating a signaling response to an external stimuli.

    Abstract translation: 具有至少一个羧酸,酯或酰胺取代的侧链的治疗化合物具有下式:CORE MOIETY - (R)j,其中j是1至3的整数。 核心部分是非环状或环状的(碳环或杂环)。 R可以选自氢,卤素,羟基,氨基,取代或未取代的C(1-10)烷基,C(2-10)烯基,碳环或杂环基,并且至少一个R具有式I:其中: 或两个p为整数,否则p为2; n为3〜20的整数。 R1选自取代和未取代的CH 2; NR 1,R 3为氢,取代或未取代的C 1-20烷基,C(1-20)烷氧基,C(2-20)烯基或C(1-20)羟基烷基或碳环或杂环基; O; -CHR4O-,R4是取代或未取代的C(1-20)烷基,C(1-20)烷氧基,C(2-20)烯基,C(1-20)羟基烷基或R2和R4连接形成取代的 或具有4-7个环原子的未取代的杂环,-CHR4O-的醚基-O-是杂环的成员。 R2选自氢; 卤素; 取代或未取代的C(1-10)烷基; C(1-10)烷氧基; C(2-10)烯基; C(1-10)羟基烯基; -A(R5)m,A是N或O,m是一个或两个,R5是氢,取代或未取代的C(1-10)烷基,C(1-10)烷氧基,C(2-10)烯基 或C(1-10)羟烷基)或碳环或杂环基。 R 1中的至少一个为NR 3,O或-CHR 4 O-,或R 2为-A(R 5)m。 这些化合物及其药物组合物可用作通过介导对外部刺激的信号反应的特异性细胞内信号通路的细胞内信号传导的疾病的治疗。

    Process for producing methyl formate
    7.
    发明授权
    Process for producing methyl formate 失效
    甲酸甲酯生产方法

    公开(公告)号:US4480122A

    公开(公告)日:1984-10-30

    申请号:US423977

    申请日:1982-09-27

    CPC classification number: C07C67/39 C07C67/40 Y10S502/524

    Abstract: A process for producing methyl formate is described by the dehydrogenation of methanol over a catalyst produced by reducing a precursor comprising copper oxide and a spinel structure support comprising the oxides of zinc and aluminum, said precursor containing 10 to 80 percent copper.

    Abstract translation: 通过甲醇脱氢催化剂描述生产甲酸甲酯的方法,所述催化剂通过还原包含氧化铜的前体和包含锌和铝的氧化物的尖晶石结构载体制备,所述前体含有10至80%的铜。

    Process for the production of methyl formate
    8.
    发明授权
    Process for the production of methyl formate 失效
    甲酸甲酯生产方法

    公开(公告)号:US4216339A

    公开(公告)日:1980-08-05

    申请号:US776369

    申请日:1977-03-10

    Abstract: The invention relates to an improved process for the production of methyl formate, wherein a current of a gas containing carbon monoxide is reacted at elevated temperature (70.degree.-110.degree. C.) and pressure (20-110 bars) in a reaction zone with a recycled current of liquid reaction mixture containing(a) methanol(b) an alkali metal or alkaline earth metal methoxide as catalyst, and(c) methyl formate produced as reaction product,part of the current of liquid reaction mixture being withdrawn in order to recover methyl formate therefrom.The characteristic feature of the invention consists in that the recycled liquid reaction mixture is used for sucking and dispersing the current of gas in the reaction mixture. Advantages of the process are: excellent heat exchange, high productivity, absence of solid deposits on the internal surfaces of the apparatus, lower operating pressures and temperatures, use of apparatus of smaller dimensions, suppression of recycling of carbon monoxide, etc.

    Abstract translation: 本发明涉及一种生产甲酸甲酯的改进方法,其中含有一氧化碳的气体的电流在升温(70-110℃)和压力(20-110巴)下在反应区中反应, 含有(a)甲醇(b)碱金属或碱土金属甲醇盐作为催化剂的液体反应混合物的回收电流,和(c)作为反应产物生产的甲酸甲酯,将部分液体反应混合物的电流抽出,以便 从其中回收甲酸甲酯。 本发明的特征在于回收的液体反应混合物用于吸收和分散反应混合物中的气体流。 该方法的优点是:优异的热交换,高生产率,设备内表面上没有固体沉积物,较低的操作压力和温度,使用较小尺寸的设备,抑制一氧化碳的再循环等。

Patent Agency Ranking